# TXA in Spinal Fusion

> **NCT04272606** · PHASE2 · COMPLETED · sponsor: **Catherine R. Olinger** · enrollment: 123 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Saline Solution
- **DIAGNOSTIC_TEST:** Visual Acuity Exam
- **DIAGNOSTIC_TEST:** 3 Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM)

## Key facts

- **NCT ID:** NCT04272606
- **Lead sponsor:** Catherine R. Olinger
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2023-06-12
- **Final completion:** 2023-06-12
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04272606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04272606, "TXA in Spinal Fusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04272606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*